A case report of successful thrombolytic therapy in stuck mechanical mitral valve in a case of post mitral valve replacement with severe left ventricular dysfunction

Authors

  • Munish Sharma Department of Medicine and Cardiologist, 151 Base Hospital, Guwahati, Assam, India
  • Anupam Pandit Department of Oral and Maxillofacial Surgery, Swami Devi Dayal Dental College, Barwala, Haryana, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20250380

Keywords:

Stuck, Mechanical valve, Severe left ventricular dysfunction, Thrombolytic, Case report

Abstract

Stuck mechanical heart valves had always been tricky to manage and there has been always a debate on how to proceed with management plan. There is uncertainty regarding the type of thrombolytic agent, its dose, and rate of administration. We are reporting a case of stuck mitral valve with extremely low left ventricular ejection fraction (LVEF) which was successfully thrombolyzed using slow thrombolytic regimen. 57 years old lady, an old case of rheumatic heart disease (RHD) with severe mitral stenosis (MS), post mitral valve replacement (mechanical SJM 29 mm) in 2013, has presented with breathlessness New York Heart Association (NYHA) class 3 since 15 days. She has history of drug default. Clinically she was in heart failure and heart sounds were muffled (no clicks). On suspicion of stuck mitral valve urgent 2D ECHO was done which confirmed stuck mitral valve leaflet, with a high mean pressure gradient across prosthetic mitral valve (MV) (18 mmHg). She had severe Pulmonary arterial hypertension with maximum gradient right ventricular systolic pressure (RVSP) of 60 mm. LVEF was 20%. Fluoroscopy is not available at our centre. She was urgently thrombolysed with 25 mg alteplase over 06 hours along with unfractionated heparin infusion @1000 u/hour for 24 hours. 2D ECHO was repeated after 24 hours which revealed leaflets of mitral valve moving freely, with MVA >2 cm2. Mean gradient was reduced to 4 mm Hg across mitral valve. Pulmonary arterial hypertension (PAH) has reduced to 36 mm. LVEF has improved to 35%. Patient has been in follow up for more than a year with sustained results. Thrombolytic agents are a good alternative for stuck mechanical valves especially when cardiothoracic surgery is unavailable at remote centres.

Metrics

Metrics Loading ...

References

Hassan Y, Awaisu A, Aziz NA, Ismail O. The complexity of achieving anticoagulation control in the face of warfarin-phenytoin interaction: an Asian case report. Pharm World Sci. 2005;27(1):16-9. DOI: https://doi.org/10.1007/s11096-004-5150-3

Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the veterans affairs randomized trial. J Am Coll Cardiol. 2000;36:1152-8. DOI: https://doi.org/10.1016/S0735-1097(00)00834-2

Karthikeyan G, Senguttuvan NB, Joseph J, Devasenapathy N, Bahl VK, Airan B. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J. 2013;34(21):1557-66. DOI: https://doi.org/10.1093/eurheartj/ehs486

Krishnan S. Prosthetic heart valve thrombosis: diagnosis and newer thrombolytic regimes. J Pract Cardiovasc Sci. 2016;2:7-12. DOI: https://doi.org/10.4103/2395-5414.182993

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. DOI: https://doi.org/10.1093/ejcts/ezac209

Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-71. DOI: https://doi.org/10.1161/CIR.0000000000000932

Bonou M, Lampropoulos K, Barbetseas J. Prosthetic heart valve obstruction: thrombolysis or surgical treatment? Eur Heart J Acute Cardiovasc Care. 2012;1:122-7. DOI: https://doi.org/10.1177/2048872612451169

Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E, et al. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging. 2013;6(2):206-16. DOI: https://doi.org/10.1016/j.jcmg.2012.10.016

Guner A, Kalcik M, Gursoy MO, Gunduz S, Ozkan M. How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis. J Thromb Thrombolysis. 2018;46(3):399-402. DOI: https://doi.org/10.1007/s11239-018-1710-6

Downloads

Published

2025-02-21

How to Cite

Sharma, M., & Pandit, A. (2025). A case report of successful thrombolytic therapy in stuck mechanical mitral valve in a case of post mitral valve replacement with severe left ventricular dysfunction. International Journal of Advances in Medicine, 12(2), 232–234. https://doi.org/10.18203/2349-3933.ijam20250380

Issue

Section

Case Reports